SWOG clinical trial number
SWOG-7424/7425

Combination Chemotherapy Utilizing BCNU Hydroxyurea and DTIC (BHD) with and without BCG and DTIC with BCG in the Treatment of Patients with Disseminated Malignant Melanoma.

Closed
Abbreviated Title
Combination Chemotherapy Utilizing BCNU Hydroxyurea and DTIC (BHD) with and without BCG and DTIC with BCG in the Treatment of Patients with Disseminated Malignant Melanoma.
Activated
10/08/1974
Closed
01/01/1977

Publication Information Expand/Collapse

1982

Combination chemotherapy pluc BCG in the treatment of disseminated malignant melanoma: A Southwest Oncology Group study.

JJ Costanzi;M Al-Sarraf;C Groppe;R Bottomley;C Fabian;J Neidhart;D Dixon Medical & Pediatric Oncology 10:251-258

1980

Chemoimmunotherapy for disseminated melanoma (DM)a

M Al-Sarraf;JJ Costanzi;DO Dixon In: Tumor Progression: Developments in Cancer Research, Volume II , 334-343

1979

Chemoimmunotherapy for disseminated melanoma.

J Costanzi;M Al-Sarraf;D Dixon ASCO, #C-293

1978

Chemotherapy and BCG in treatment of disseminated malignant melanoma.

JJ Costanzi In: Immunotherapy of Cancer Present Status of Trials in Man, pp. 87-93

Value of cellular mediating immunity in patients with disseminated melanoma treated with chemoimmuno- therapy.

M Al-Sarraf;J Costanzi AACR (#49)

Prognostic value of pre-therapy total peripheral lymphocites and white blood cells in patients with advanced malignant melanoma.

M Al-Sarraf;J Costanzi ASCO (#C-15)

1977

Chemotherapy and BCG in the treatment of disseminated melanoma: A Southwest Oncology Group study.

JJ Costanzi AACR, #455

1976

Combination chemoimmunotherapy for disseminated malignant melanoma (DMM).

JJ Costanzi ASCO, #C- 18